• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有潜在肝硬化的乙型肝炎病毒相关肝细胞癌中的血管侵犯:与腹水及乙型肝炎病毒因素的可能关联?

Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?

作者信息

Chen Chuan, Chen Dong-Ping, Gu Yan-Yan, Hu Liang-Hao, Wang Dan, Lin Jin-Huan, Li Zhao-Shen, Xu Jing, Wang Ge

机构信息

Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, No. 10 Changjiang Zhi Rd, Chongqing, 400042, China.

出版信息

Tumour Biol. 2015 Aug;36(8):6255-63. doi: 10.1007/s13277-015-3311-8. Epub 2015 Apr 2.

DOI:10.1007/s13277-015-3311-8
PMID:25833692
Abstract

Vascular invasion is one of the most important prognostic factors for patients with hepatocellular carcinoma (HCC). The objective of the current, retrospective study was to determine the associations of ascites and hepatitis B viral factors (HBeAg and anti-HBe status and HBV DNA levels), as well as tumor-related factors (size, tumor number, grade, and location) with micro- or macroscopic vascular invasion in patients with HCC that developed as a result of hepatitis B virus (HBV)-related cirrhosis. A total of 336 consecutive patients were included. Potential factors associated with micro- or macroscopic vascular invasion were analyzed by logistic regression. Ascites were more commonly detected in patients with micro- or macroscopic vascular invasion, and the presence of ascites was independently associated with vascular invasion. Among patients with mild-to-moderate or severe ascites, the odds ratio for macroscopic vascular invasion was 4.83 (95 % confidence interval [CI] 2.29-10.16) and 11.87 (95 % CI 4.53-31.07), respectively. Similarly, the presence of ascites was associated with microscopic vascular invasion (OR 5.00; 95 % CI 1.23-20.31). In contrast, hepatitis B viral factors were not significantly associated with vascular invasion. The presence of ascites was associated with vascular invasion in patients with HBV-related cirrhotic HCC. Thus, patients with ascites, vascular invasion should be considered and more frequent surveillance should be performed after curative treatment.

摘要

血管侵犯是肝细胞癌(HCC)患者最重要的预后因素之一。本项回顾性研究的目的是确定腹水和乙型肝炎病毒因素(HBeAg和抗-HBe状态以及HBV DNA水平),以及肿瘤相关因素(大小、肿瘤数量、分级和位置)与因乙型肝炎病毒(HBV)相关肝硬化而发生的HCC患者微血管或大血管侵犯之间的关联。总共纳入了336例连续患者。通过逻辑回归分析与微血管或大血管侵犯相关的潜在因素。微血管或大血管侵犯患者中更常检测到腹水,并且腹水的存在与血管侵犯独立相关。在轻度至中度或重度腹水患者中,大血管侵犯的比值比分别为4.83(95%置信区间[CI]2.29-10.16)和11.87(95%CI 4.53-31.07)。同样,腹水的存在与微血管侵犯相关(比值比5.00;95%CI 1.23-20.31)。相比之下,乙型肝炎病毒因素与血管侵犯无显著关联。腹水的存在与HBV相关肝硬化HCC患者的血管侵犯有关。因此,对于有腹水、血管侵犯的患者应予以考虑,并在根治性治疗后进行更频繁的监测。

相似文献

1
Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors?伴有潜在肝硬化的乙型肝炎病毒相关肝细胞癌中的血管侵犯:与腹水及乙型肝炎病毒因素的可能关联?
Tumour Biol. 2015 Aug;36(8):6255-63. doi: 10.1007/s13277-015-3311-8. Epub 2015 Apr 2.
2
Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.轻度肝硬化和血清HBeAg转阴并不意味着乙肝相关肝硬化患者发生肝细胞癌的风险较低。
Med Sci Monit. 2009 Jun;15(6):CR274-9.
3
Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.乙型肝炎包膜抗原阴性预测乙型肝炎病毒相关肝细胞癌消融治疗后肝内复发。
J Gastroenterol Hepatol. 2011 Nov;26(11):1638-45. doi: 10.1111/j.1440-1746.2011.06777.x.
4
Possible associations between ascites and vascular invasion in patients with hepatocellular carcinoma.肝细胞癌患者腹水与血管侵犯之间可能的关联。
Tumour Biol. 2015 Jul;36(7):4933-4. doi: 10.1007/s13277-015-3521-0. Epub 2015 May 3.
5
High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.活体肝移植后乙肝病毒DNA/乙肝e抗原阳性肝细胞癌患者的大剂量乙肝免疫球蛋白治疗
World J Gastroenterol. 2016 Apr 14;22(14):3803-12. doi: 10.3748/wjg.v22.i14.3803.
6
Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.乙型肝炎病毒基因混合体、C2和B2亚基因型在肝细胞癌中的作用:与同一地区慢性乙型肝炎和无症状携带者状态的比较。
Carcinogenesis. 2008 Sep;29(9):1685-91. doi: 10.1093/carcin/bgm301. Epub 2008 Jan 12.
7
Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.外周血单个核细胞中A20基因表达的改变与慢性乙型肝炎病毒感染的进展相关。
Oncotarget. 2016 Oct 18;7(42):68821-68832. doi: 10.18632/oncotarget.11993.
8
Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma.乙型肝炎病毒感染和活跃复制促进肝细胞癌中血管侵犯的形成。
BMC Cancer. 2017 May 2;17(1):304. doi: 10.1186/s12885-017-3293-6.
9
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.携带不活动乙肝病毒的人仍然有患肝细胞癌和与肝脏相关死亡的风险。
Gastroenterology. 2010 May;138(5):1747-54. doi: 10.1053/j.gastro.2010.01.042. Epub 2010 Jan 28.
10
Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.乙型肝炎病毒因素与慢性乙型肝炎的临床结局
J Biomed Sci. 2008 Mar;15(2):137-45. doi: 10.1007/s11373-007-9225-8. Epub 2007 Dec 5.

引用本文的文献

1
Single-cell and bulk transcriptomic datasets enable the development of prognostic models based on dynamic changes in the tumor immune microenvironment in patients with hepatocellular carcinoma and portal vein tumor thrombus.单细胞和批量转录组数据集使基于肝癌和门静脉癌栓患者肿瘤免疫微环境动态变化的预后模型的开发成为可能。
Front Immunol. 2024 Oct 28;15:1414121. doi: 10.3389/fimmu.2024.1414121. eCollection 2024.
2
Clinical application of spectral CT perfusion scanning in evaluating the blood supply source of portal vein tumor thrombus in hepatocellular carcinoma.光谱CT灌注扫描在评估肝细胞癌门静脉癌栓血供来源中的临床应用
Front Oncol. 2024 Jan 17;13:1348679. doi: 10.3389/fonc.2023.1348679. eCollection 2023.
3

本文引用的文献

1
Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy.肝细胞癌患者的腹水:患病率、相关因素、预后影响及分期策略。
Hepatol Int. 2013 Mar;7(1):188-98. doi: 10.1007/s12072-011-9338-z. Epub 2012 Jan 8.
2
Vascular invasion affects survival in early hepatocellular carcinoma.血管侵犯影响早期肝细胞癌的生存率。
Mol Clin Oncol. 2015 Jan;3(1):252-256. doi: 10.3892/mco.2014.420. Epub 2014 Sep 18.
3
Identification of melanoma biomarkers based on network modules by integrating the human signaling network with microarrays.
Innovative Synoptic Reporting With Seven-Point Sampling Protocol to Improve Detection Rate of Microvascular Invasion in Hepatocellular Carcinoma.
采用七点采样方案的创新型概要报告以提高肝细胞癌微血管侵犯的检出率
Front Oncol. 2021 Nov 4;11:726239. doi: 10.3389/fonc.2021.726239. eCollection 2021.
4
Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides.门静脉肿瘤血栓形成与肝细胞癌——变化的趋势
J Hepatocell Carcinoma. 2021 Sep 7;8:1089-1115. doi: 10.2147/JHC.S318070. eCollection 2021.
5
Prediction factors of tolvaptan effectiveness in patients with refractory ascites complicated with hepatocellular carcinoma.预测托伐普坦治疗合并肝细胞癌难治性腹水患者疗效的相关因素。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e161-e166. doi: 10.1097/MEG.0000000000001985.
6
Serum metabolites may be useful markers to assess vascular invasion and identify normal alpha-fetoprotein in hepatocellular carcinoma undergoing liver resection: a pilot study.血清代谢物可作为评估血管侵犯和识别行肝切除术的肝细胞癌中正常甲胎蛋白的有用标志物:一项初步研究。
World J Surg Oncol. 2020 Jun 3;18(1):121. doi: 10.1186/s12957-020-01885-w.
7
Effects of various interventions on the occurrence of macrovascular invasion of hepatocellular carcinoma after the baseline serum γ-glutamyltransferase stratification.基线血清γ-谷氨酰转移酶分层后,各种干预措施对肝细胞癌大血管侵犯发生情况的影响。
Onco Targets Ther. 2019 Feb 28;12:1671-1679. doi: 10.2147/OTT.S184302. eCollection 2019.
8
A new scoring model predicting macroscopic vascular invasion of early-intermediate hepatocellular carcinoma.一种预测早期-中期肝细胞癌宏观血管侵犯的新评分模型。
Medicine (Baltimore). 2018 Dec;97(49):e13536. doi: 10.1097/MD.0000000000013536.
9
Need for normalization: the non-standard reference standard for microvascular invasion diagnosis in hepatocellular carcinoma.需要规范化:肝细胞癌微血管侵犯诊断中的非标准参考标准。
World J Surg Oncol. 2018 Mar 7;16(1):50. doi: 10.1186/s12957-018-1347-0.
10
Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma.托伐普坦治疗晚期肝细胞癌的疗效。
World J Gastroenterol. 2017 Aug 7;23(29):5379-5385. doi: 10.3748/wjg.v23.i29.5379.
通过将人类信号网络与微阵列相结合,基于网络模块鉴定黑色素瘤生物标志物。
J Cancer Res Ther. 2014 Nov;10 Suppl:C114-24. doi: 10.4103/0973-1482.145816.
4
Management of hepatocellular carcinoma.肝细胞癌的管理
J Cancer Res Clin Oncol. 2015 May;141(5):861-76. doi: 10.1007/s00432-014-1806-0. Epub 2014 Aug 27.
5
Hepatocellular carcinoma: carcinogenesis, establishment, progression, and therapies.肝细胞癌:致癌作用、形成、进展及治疗
Biomed Res Int. 2014;2014:706142. doi: 10.1155/2014/706142. Epub 2014 Jun 17.
6
Incidental hepatocellular carcinoma: risk factors and long-term outcome after liver transplantation.偶发性肝细胞癌:肝移植后的危险因素及长期预后
Transplant Proc. 2014 Jun;46(5):1426-9. doi: 10.1016/j.transproceed.2014.03.010.
7
Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.抗病毒治疗对乙型肝炎相关肝细胞癌肝切除术后结局的影响。
World J Gastroenterol. 2014 May 28;20(20):6006-12. doi: 10.3748/wjg.v20.i20.6006.
8
Risk of tumor cell seeding through biopsy and aspiration cytology.通过活检和细针穿刺吸取细胞学检查导致肿瘤细胞种植的风险。
J Int Soc Prev Community Dent. 2014 Jan;4(1):5-11. doi: 10.4103/2231-0762.129446.
9
Predictors of microvascular invasion in patients with solitary small hepatitis B related hepatocellular carcinoma.预测单发小肝癌患者的微血管侵犯。
Pak J Med Sci. 2014 Mar;30(2):331-4. doi: 10.12669/pjms.302.4652.
10
The diagnosis and treatment of hepatocellular carcinoma.肝细胞癌的诊断与治疗。
Dtsch Arztebl Int. 2014 Feb 14;111(7):101-6. doi: 10.3238/arztebl.2014.0101.